Language:

Topical interferon - A novel treatment for pseudophakic macular edema

Indian journal of ophthalmology, 2021-09, Vol.69 (9), p.2355-2360 [Peer Reviewed Journal]

COPYRIGHT 2021 Medknow Publications and Media Pvt. Ltd. ;2021. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright: © 2021 Indian Journal of Ophthalmology 2021 ;ISSN: 0301-4738 ;EISSN: 1998-3689 ;DOI: 10.4103/ijo.IJO_2704_20 ;PMID: 34427221

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Topical interferon - A novel treatment for pseudophakic macular edema
Author: Kawali, Ankush ; Snehith, Ram ; Singh, Vivek ; Sanjay, Srinivasan ; Mahendradas, Padmamalini ; Shetty, Rohit
Subjects: Conjunctivitis ; cystoid macular edema ; Dosage and administration ; Drug therapy ; Edema ; Eye ; Eye diseases ; Growth factors ; Humans ; Interferon ; Interferons ; irvine–gass syndrome ; Macular Edema - diagnosis ; Macular Edema - drug therapy ; Macular Edema - etiology ; Ophthalmic drugs ; Original ; Patient outcomes ; Patients ; postoperative macular edema ; postoperative uveitis ; Prospective Studies ; pseudophakic macular edema ; Steroid hormones ; Tomography, Optical Coherence ; topical interferon ; Visual Acuity
Is Part Of: Indian journal of ophthalmology, 2021-09, Vol.69 (9), p.2355-2360
Description: Purpose: The aim of this study was to evaluate the efficacy of topical interferon (IFN) therapy in pseudophakic cystoid macular edema (P-CME). Methods: This is a prospective, interventional case series of patients with P-CME. Patients presenting with P-CME were given the option of topical IFN therapy against conventional treatment with oral, topical, intravitreal, and periocular steroid therapy and antivascular growth factors. Patients who consented for the same were advised to use the IFN drops four times/day. Commercially available injection IFN alfa-2b was reconstituted to prepare the eye drops (1 MIU/ml). Optical coherence tomography (OCT) was done at the baseline and on each review visit until complete resolution of P-CME. Results: Eight eyes of eight patients diagnosed with P-CME were studied. Mean central macular thickness (CMT) on OCT at the presentation (n = 8) and at 4 weeks post topical IFN therapy (n = 6) was 560.1 μm (range: 349-702 μm) and 344.33 μm (range: 250-390 μm), respectively. All eyes except one had posterior capsular rent (PCR). Five patients had regular follow-up until resolution. The mean duration of complete first resolution of P-CME was 5 weeks (range: 4-7.1 weeks) in those patients. Relapse was seen in three patients who responded after resuming or continuing the therapy. Case 1 had 9 months follow-up after completion of IFN therapy, and no recurrence was noted. No ocular or systemic side effects related to the topical IFN therapy were noted clinically, except papillary conjunctivitis in one patient. Conclusion: Topical IFN therapy can be a noninvasive, economical, and effective choice of treatment for P-CME, especially in the case of PCR, and where steroids are contraindicated.
Publisher: India: Wolters Kluwer India Pvt. Ltd
Language: English
Identifier: ISSN: 0301-4738
EISSN: 1998-3689
DOI: 10.4103/ijo.IJO_2704_20
PMID: 34427221
Source: GFMER Free Medical Journals
MEDLINE
PubMed Central
Medknow Open Access Medical Journals
ProQuest Central
DOAJ Directory of Open Access Journals

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Topical interferon - A novel treatment for pseudophakic macular edema

Searching Remote Databases, Please Wait